HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.

AbstractOBJECTIVE:
To review the incidence of respiratory conditions and their effect on mortality in HIV-infected and uninfected individuals prior to and during the era of highly active antiretroviral therapy (HAART).
DESIGN:
Two large observational cohorts of HIV-infected and HIV-uninfected men (Multicenter AIDS Cohort Study [MACS]) and women (Women's Interagency HIV Study [WIHS]), followed since 1984 and 1994, respectively.
METHODS:
Adjusted odds or hazards ratios for incident respiratory infections or non-infectious respiratory diagnoses, respectively, in HIV-infected compared to HIV-uninfected individuals in both the pre-HAART (MACS only) and HAART eras; and adjusted Cox proportional hazard ratios for mortality in HIV-infected persons with lung disease during the HAART era.
RESULTS:
Compared to HIV-uninfected participants, HIV-infected individuals had more incident respiratory infections both pre-HAART (MACS, odds ratio [adjusted-OR], 2.4; 95% confidence interval [CI], 2.2-2.7; p<0.001) and after HAART availability (MACS, adjusted-OR, 1.5; 95%CI 1.3-1.7; p<0.001; WIHS adjusted-OR, 2.2; 95%CI 1.8-2.7; p<0.001). Chronic obstructive pulmonary disease was more common in MACS HIV-infected vs. HIV-uninfected participants pre-HAART (hazard ratio [adjusted-HR] 2.9; 95%CI, 1.02-8.4; p = 0.046). After HAART availability, non-infectious lung diseases were not significantly more common in HIV-infected participants in either MACS or WIHS participants. HIV-infected participants in the HAART era with respiratory infections had an increased risk of death compared to those without infections (MACS adjusted-HR, 1.5; 95%CI, 1.3-1.7; p<0.001; WIHS adjusted-HR, 1.9; 95%CI, 1.5-2.4; p<0.001).
CONCLUSION:
HIV infection remained a significant risk for infectious respiratory diseases after the introduction of HAART, and infectious respiratory diseases were associated with an increased risk of mortality.
AuthorsMatthew R Gingo, G K Balasubramani, Lawrence Kingsley, Charles R Rinaldo Jr, Christine B Alden, Roger Detels, Ruth M Greenblatt, Nancy A Hessol, Susan Holman, Laurence Huang, Eric C Kleerup, John Phair, Sarah H Sutton, Eric C Seaberg, Joseph B Margolick, Stephen R Wisniewski, Alison Morris
JournalPloS one (PLoS One) Vol. 8 Issue 3 Pg. e58812 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23554932 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
Topics
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Female
  • HIV Infections (complications, drug therapy, mortality)
  • Humans
  • Incidence
  • Longitudinal Studies
  • Lung Diseases (epidemiology, etiology)
  • Male
  • Respiration Disorders (epidemiology, etiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: